Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxylamine versus noradrenaline for septic shock
ChiCTR1900027116Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydroxylamine and norepinephrine in septic shock (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: 28-day mortality. Started Nov 2019; status: recruiting.
02
Drugs
hydroxylaminenorepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR1900027116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027116.